- About Us
- Nano-Social Network
- Nano Consulting
- My Account
Shares will commence trading on AIM today
Oxonica plc (“Oxonica”), the holding company of one of Europe’s leading nanomaterials groups, announces that following a successful placing, its ordinary shares will commence trading on AIM today.
Commenting on the Placing and Admission, Dr Kevin Matthews, Chief Executive of Oxonica said:
“We are delighted both to have had such a positive response to our fundraising and with today's admission to AIM. The listing and strengthened balance sheet will enhance our profile and visibility with global strategic partners as we seek to develop innovative nanotechnology solutions internationally. Oxonica is already well positioned within the nanotechnology market and we are excited about the future prospects of this evolving industry.”
About Oxonica plc:
Oxonica is one of the leading European nanomaterials groups with products already launched into international markets. It was spun-out from Oxford University in 1999 and currently employs 37 professional staff.
Oxonica’s mission is to develop innovative commercial solutions for international markets using its expertise in the design and application of nanomaterials.
The company has three operating divisions: Oxonica Energy, Oxonica Healthcare and Oxonica Materials.
Commercialised products are:
Envirox™ Fuel Borne Catalyst – a fuel borne nanocatalyst for diesel engines which reduces fuel consumption with savings of 5-10% and reduces particulate emissions by up to 15%. The product has already been adopted by Stagecoach Group in the UK and in New Zealand and is distributed by DMX Technology Corporation to petroleum companies in the Philippines for use in a premium diesel.
Optisol™ UV Absorber – a photostable UV absorber that provides enhanced and longer lasting protection against UVA in sun-care and anti-ageing products. Optisol™ also reduces the formation of free radicals produced from exposure to the sun and which are implicated in premature skin ageing. Boots Group plc is the first to incorporate Optisol™ in their new Soltan Facial Sun Defense Cream for 2005.
In addition, Oxonica is working to generate a range of future product applications. These include additional fuel saving additives, marker technology for the clinical and life science diagnostics markets, further UV protection applications, including tailoring the Optisol™ product in the cosmetics markets, and new products for plastics and coatings, transparent conducting films and security markers.
Optisol™ and Envirox™ are trademarks of Oxonica.
For more information, please visit www.oxonica.com
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Arrowhead Provides Response to New Minority Shareholder Announcement January 7th, 2017
Harris & Harris Group Announces a Proposed Strategic Restructuring December 20th, 2016
Particles from outer space are wreaking low-grade havoc on personal electronics February 19th, 2017
Engineers shrink microscope to dime-sized device February 17th, 2017
Arrowhead Pharmaceuticals to Webcast Fiscal 2017 First Quarter Results January 31st, 2017
Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016